Cellectar Biosciences
CLRB • NASDAQ
Cellectar Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James V. Caruso, with a market cap of $11.4M.
Market Cap$11.4M
Employees20.0
CEOJames V. Caruso
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Cellectar Biosciences FAQ
Common questions about Cellectar Biosciences
Cellectar Biosciences is scheduled to report earnings for Q1 2026 on May 12, 2026.
Cellectar Biosciences has approximately 20 employees.